Sign in
Taking peopleNo phase

Glucose Consumption During Deep Brain Stimulation With Functional [18F]FDG-Brain-PET in Obsessive-Compulsive Disorder

Key facts

Who runs it
Medical University of Vienna
Where
Austria1 site in 1 countryChoose a country to see its sites
Trial code
Status
Recruiting
People taking part
8 people, planned
Started
1 Apr 2022
Planned end
1 Sept 2026
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Implantation of a DBS therapy system
Record updated
13 June 2025

Who can take part

Age
18 years to 75 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 16 criteriaShow less

Who can take part

  • a score of 25 or higher on the Yale-Brown Obsessive Compulsive Scale
  • previous failure to respond to at least two medication trials with serotonin reuptake inhibitors at or, if tolerated, beyond the FDA maximum recommended dose for a minimum duration over at least ten weeks each
  • at least one trial with tricyclic medication at or, if tolerated, beyond the FDA maximum recommended dose for a minimum duration over at least ten weeks each
  • at least one trial of augmentation with antipsychotic medication, lithium, a benzodiazepine or buspirone
  • at least on trial of psychotherapy (cognitive behavioral therapy or comparable techniques) for at least 20 sessions
  • ability to provide written informed consent

Who cannot take part

  • any history of current or past psychotic disorder
  • any current clinically significant medical or neurological disorder, that is a contraindication against DBS
  • Any current severe personality disorder except comorbid anankastic personality disorder
  • any disease that could lead to an altered glucose reactivity (e.g. diabetes)
  • a manic episode within the preceding three years
  • any clinically significant preoperative MRI abnormality or inability to undergo presurgical MRI
  • current or unstable remitted substance abuse or dependence except nicotine
  • pregnancy or high risk of becoming pregnant during study duration (desire to have children) and refusal to utilize a proper method of contraception
  • Inability to follow the study protocol or adhere to operational requirements
  • Current and unstable suicidality

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 75 years old?

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The purpose of this randomized, sham-controlled study is to evaluate the effectiveness of DBS therapy in individuals suffering from severe OCD and to investigate DBS treatment with functional [18F]FDG-Brain-PET.

The 2 groups in the trial

  • Subjects in this arm will receive active stimulation.Existing treatment, for comparison

    The Medtronic DBS system will be implanted in subjects in both study arms. Stimulation will vary depending on the study arm assignment. All subjects will receive therapeutic settings at the end of the blinded period.

    Treatment: Implantation of a DBS therapy system

  • Subjects in this arm will receive sham stimulation with DBS being turned off.Sham treatment, for comparison

    The Medtronic DBS system will be implanted in subjects in both study arms. Stimulation will vary depending on the study arm assignment. All subjects will receive therapeutic settings at the end of the blinded period.

    Treatment: Implantation of a DBS therapy system

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Fit questions
Built from NCT05577598, who can take part
Record updated
13 June 2025